Skip to content

Volumetric Changes and Graft Stability in Lateral Window Sinus Augmentation: A Prospective Clinical Trial

Volumetric Changes and Graft Stability in Lateral Window Sinus Augmentation: A Prospective Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03639077
Enrollment
19
Registered
2018-08-20
Start date
2018-10-01
Completion date
2020-09-09
Last updated
2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Window Sinus Augmentation

Keywords

Bone graft, Lateral window approach, Sinus augmentation, Volumetric change

Brief summary

The purpose of this study is to evaluate the stability and volumetric changes of the grafting materials used for lateral window sinus augmentation. In addition, different variables known to affect bone stability and remodeling with regard to the augmentation procedure will be evaluated. Similarly, implant placement will be performed and results will be evaluated after a period of six months.

Detailed description

This will be a prospective clinical study evaluating the stability and volumetric change of two grafting materials used in lateral window sinus augmentation procedure (anorganic bovine bone xenograft alone compared to a mixture of allograft and anorganic bovine bone xenograft). Participants will have the same surgical treatment of the lateral window sinus augmentation procedure. Participants will have a simultaneous implant placement at the time of sinus augmentation procedure or a delayed implant placement based on the stability of the implant evaluation. Cone beam computed tomography (CBCT) will be used to evaluate the volumetric changes between two groups of graft material in sinus augmentation procedure at three time points: pre-operatively, two weeks post-operation and six months post-operation. Biopsies will be harvested after six months for histological and histomorphometric analysis.

Interventions

DEVICEAllograft bone alone

The subject will receive an allograft as graft material of choice for sinus augmentation

DEVICEAllograft and xenograft mixture

The subjects will receive a mixture of allograft and anorganic bovine bone xenograft as graft material of choice for sinus augmentation

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adult patients ≥ 18 years old 2. In need of sinus augmentation utilizing lateral window sinus technique 3. Presence of bone height of \< 8 mm 4. Patient has good oral hygiene (\<40% plaque score) 5. Periodontally stable 6. Willingness to fulfill all study requirements

Exclusion criteria

1. Currently smoking \> 10 cigarettes / day 2. Pregnant, expecting to become pregnant or lactating mothers 3. Uncontrolled Diabetes Mellitus (HbA1c \>7) 4. Medical condition that may influence the outcome (Neurologic or psychiatric disorders, systemic infections) 5. Current use of oral bisphosphonates 6. History of IV bisphosphonates use 7. Poor oral hygiene (plaque score \>40% based on O'Leary plaque score) 8. Unmanageable Sinus perforations 9. Significant pathology in the region of interest that may compromise the procedure

Design outcomes

Primary

MeasureTime frameDescription
Graft volumetric stability changeCBCT taken at 2 weeks after the procedure and 6 months after the procedure of sinus augmentation to assess the volumetric changes of the graft materialCBCT will be the primary tool to evaluate the volumetric stability of the graft material used in the sinus augmentation procedure

Secondary

MeasureTime frameDescription
Histomorphometric analysisAfter 6 months of sinus augmentation procedure when the implant is placedIdentify histological differences between two groups of graft material in sinus augmentation procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026